Carboplatin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Carboplatin Injection (injection) from Teyro Labs with status Current. The shortage was first posted on 04/28/2023. Reported reason: Discontinuation of the manufacture of the drug
Shortage Details
- Status
- Current
- Company
- Teyro Labs
- Package NDC
- 60505-6282-7
- Dosage Form
- Injection
- Presentation
- Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7)
- Initial Posting
- 04/28/2023
- Revised Date
Reason
Discontinuation of the manufacture of the drug